-
-
[1] Greenwood EA, Noel MW, Kao CN, et al. Vigorous exercise is associated with superior metabolic profiles in polycystic ovary syndrome independent of total exercise expenditure[J]. Ferti lSteril, 2016, 105:486-493. doi: 10.1016/j.fertnstert.2015.10.020 [2] Ganie MA, Dhingra A, Nisar S, et al. Oral glucose tolerance test significantly impacts the prevalence of abnormal glucose tolerance among Indian women with polycystic ovary syndrome: lessons from a large database of two tertiary care centers on the Indian subcontinent[J]. Fertil Steril, 2016, 105:194-201.e3. doi: 10.1016/j.fertnstert.2015.09.005 [3] Lee H, Oh JY, Sung YA, et al. A genetic risk score is associated with polycystic ovary syndrome-related traits[J]. Hum Reprod, 2016, 31:209-215. doi: 10.1093/humrep/dev282 [4] Zeleke BM, Bell RJ, Billah B, et al. Vasomotor and sexual symptoms in older Australian women: a cross-sectional study[J]. Fertil Steril, 2016, 105:149-155.e1. doi: 10.1016/j.fertnstert.2015.09.017 [5] Palma F, Volpe A, Villa P, et al. Vaginal atrophy of women in postmenopause. Results from a multicentric observational study: The AGATA study[J]. Maturitas, 2016, 83: 40-44. https://www.researchgate.net/publication/282345828_Vaginal_atrophy_of_women_in_postmenopause_Results_from_a_multicentric_observational_study_The_AGATA_study?ev=auth_pub [6] Watt FE. Hand osteoarthritis, menopause and menopausal hormone therapy[J]. Maturitas, 2016, 83:13-18. doi: 10.1016/j.maturitas.2015.09.007 [7] Yaralizadeh M, Abedi P, Najar S, et al. Effect of Foeniculum vulgare (fennel) vaginal cream on vaginal atrophy in postmenopausal women: A double-blind randomized placebo-controlled trial[J]. Maturitas, 2016, 84:75-80. doi: 10.1016/j.maturitas.2015.11.005 [8] Antoine C, Ameye L, Paesmans M, et al. Menopausal hormone therapy use in relation to breast cancer incidence in 11 European countries[J]. Maturitas, 2016, 84:81-88. doi: 10.1016/j.maturitas.2015.11.010 [9] National Institute for Health and Care Excellence. Menopause: diagnosis and management of menopause. NICE guideline[NG 23][EB/OL]. (2015-11-12)https://www.nice.org.uk/guidance/ng23/resources/menopause-diagnosis-and-management-1837330217413. [10] Solomon CG, Black DM, Rosen CJ. Postmenopausal Osteoporosis[J]. N Engl J Med, 2016, 374:254-262. doi: 10.1056/NEJMcp1513724 [11] Jiang X, Good LE, Spinka R, et al. Osteoporosis screening in postmenopausal women aged 50-64 years: BMI alone compared with current screening tools[J]. Maturitas, 2016, 83:59-64. doi: 10.1016/j.maturitas.2015.09.009 [12] Coronado PJ, Sánchez-Borrego R, Ruiz MA, et al. Psychometric attributes of the Cervantes short-form questionnaire for measuring health-related quality of life in menopausal women[J]. Maturitas, 2016, 84:55-62. doi: 10.1016/j.maturitas.2015.10.013 [13] Ruth KS, Beaumont RN, Tyrrell J, et al. Genetic evidence that lower circulating FSH levels lengthen menstrual cycle, increase age at menopause and impact female reproductive health[J]. Hum Reprod, 2016, 31:473-481. doi: 10.1093/humrep/dev318 [14] Różycka A, Słopień R, Słopień A, et al. The MAOA, COMT, MTHFR and ESR1 gene polymorphisms are associated with the risk of depression in menopausal women[J]. Maturitas, 2016, 84:42-54. doi: 10.1016/j.maturitas.2015.10.011 [15] Peck JD, Quaas AM, Craig LB, et al. Lifestyle factors associated with histologically derived human ovarian non-growing follicle count in reproductive age womendagger[J]. Hum Reprod, 2016, 31:150-157. doi: 10.1093/humrep/dev271 [16] Bradley LD, Gueye N-A. The medical management of abnormal uterine bleeding in reproductive-aged women[J]. Am J Obstet Gynecol, 2016, 214:31-44. doi: 10.1016/j.ajog.2015.07.044
点击查看大图
计量
- 文章访问数: 104
- HTML全文浏览量: 25
- PDF下载量: 20
- 被引次数: 0